v3.21.2

Condensed and Consolidated Balance Sheets (unaudited) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets
Cash	$ 588	$ 215,836
Prepaid expenses	41,293	61,757
Total current assets	41,881	277,593
Non-current assets
Property and equipment, net	34,730	50,763
Intangible assets, net	3,160,968	3,664,343
Total non-current assets	3,195,698	3,715,106
Total assets	3,237,579	3,992,699
Current liabilities
Accounts payable and accrued expenses	129,233	3,164
Total current liabilities	129,233	3,164
Long-term liabilities
Notes payable	2,322,226	2,245,831
Total liabilities	2,451,459	2,248,995
Total preferred stock subject to possible redemption	3,569,594	3,569,594
Stockholders' deficit
Preferred Stock	1,379,012	1,236,228
Common Stock, $0.001 par value; 780,000,000 shares authorized, 5,881,898 shares issued and outstanding at June 30, 2021 and December 31, 2020	5,882	5,882
Additional paid-in capital	11,982,627	12,015,552
Accumulated deficit	(16,150,995)	(15,083,552)
Total stockholders' deficit	(2,783,474)	(1,825,890)
Total liabilities and stockholders' deficit	3,237,579	3,992,699
Series A Preferred Stock [Member]
Long-term liabilities
Total preferred stock subject to possible redemption	3,029,579	3,029,579
Series A 2 Preferred Stock [Member]
Long-term liabilities
Total preferred stock subject to possible redemption	$ 540,015	$ 540,015

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

EVOLUTIONARY GENOMICS, INC. 10-Q